BioLife Solutions, Inc.
BLFS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $29 | $32 | $67 | $95 |
| Short-Term Investments | $49 | $50 | $22 | $9 |
| Receivables | $11 | $10 | $9 | $9 |
| Inventory | $28 | $28 | $28 | $29 |
| Other Curr. Assets | $9 | $6 | $6 | $6 |
| Total Curr. Assets | $127 | $125 | $131 | $149 |
| Property Plant & Equip (Net) | $19 | $17 | $17 | $17 |
| Goodwill | $212 | $212 | $212 | $212 |
| Intangibles | $7 | $8 | $9 | $10 |
| Long-Term Investments | $0 | $24 | $20 | $6 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $27 | $0 | $6 | $6 |
| Total NC Assets | $266 | $262 | $264 | $251 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $392 | $387 | $395 | $399 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $3 | $4 |
| Short-Term Debt | $10 | $12 | $12 | $12 |
| Tax Payable | $4 | $4 | $4 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $11 | $9 | $8 | $12 |
| Total Curr. Liab. | $27 | $28 | $28 | $33 |
| LT Debt | $11 | $12 | $15 | $18 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $11 | $12 | $15 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $14 | $14 | $14 |
| Total Liabilities | $38 | $40 | $43 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$351 | -$351 | -$336 | -$335 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $704 | $698 | $688 | $684 |
| Total Equity | $354 | $347 | $353 | $349 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $392 | $387 | $395 | $399 |
| Net Debt | -$9 | -$8 | -$40 | -$65 |